Status:

UNKNOWN

Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients

Lead Sponsor:

Lee's Pharmaceutical Limited

Conditions:

Kidney Transplant Immunosuppression

Eligibility:

All Genders

18-75 years

Phase:

PHASE4

Brief Summary

This prospective, randomized controlled study is intended to enroll 152 patients in the early stages of donor kidney transplantation at six clinical centers in China between January 2023 and January 2...

Detailed Description

This is a multi-center, prospective, non-inferior, randomized controlled clinical study. The sick individuals and their families participating in the trial voluntarily participate and sign the "inform...

Eligibility Criteria

Inclusion

  • 1\) After donor kidney transplantation;
  • 2\) Adult recipients aged 18-75 years, regardless of gender;
  • 3\) First-time kidney transplant recipients;
  • 4\) Voluntarily sign written informed consent.

Exclusion

  • 1\) Multiple organ transplantation;
  • 2\) DSA positive patients had ABO incompatibility and PRA\>30%;
  • 3\) Recipients with active signs of infection;
  • 4\) Recipients with leukocyte counts below 3,000/mm3;
  • 5\) Pregnant women, breastfeeding women or women who do not wish to use appropriate contraceptive methods during the study period;
  • 6\) Patients with severe gastrointestinal diseases and active peptic ulcer disease;
  • 7\) suffering from any mental illness;
  • 8\) Patients with severe heart disease and abnormal heart function;
  • 9\) Subjects who are known to be allergic to the test drug;
  • 10\) Recipients judged unsuitable for inclusion by other competent physicians.

Key Trial Info

Start Date :

January 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

152 Patients enrolled

Trial Details

Trial ID

NCT06114953

Start Date

January 1 2023

End Date

March 1 2025

Last Update

November 2 2023

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

The Second Affiliated Hospital of Guangxi Medical University

Nanning, Guangxi, China

2

Affiliated Hospital of Guizhou Medical University

Guiyang, Guizhou, China

3

First Affiliated Hospital of Zhengzhou University

Zhengzhou, Henan, China

4

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

Wuhan, Hubei, China